KEROS THERAPEUTICS INC (KROS) Stock Cash Flow
NASDAQ:KROS - Nasdaq - US4923271013 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -181.57M | -152.99M | -104.68M | -58.74M | -45.36M | |||
| Depreciation Amortization | 1.14M | 815.00K | 670.00K | 380.00K | 280.00K | |||
| Change In Working Capital | 5.53M | -2.65M | 14.31M | -16.07M | 2.28M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 34.58M | 30.32M | 19.64M | 12.29M | 5.91M | |||
| OPERATING CASH FLOW | -140.32M | -124.51M | -70.06M | -62.15M | -36.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.19M | -2.46M | -1.24M | -1.02M | -290.00K | |||
| INVESTING CASH FLOW | -2.19M | -2.46M | -1.24M | -1.02M | -290.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 386.05M | 179.05M | 120.40M | 28.55M | 299.24M | |||
| Other Financing Activity | -518.00K | -94.00K | -90.00K | 0.00 | -3.20M | |||
| FINANCING CASH FLOW | 385.53M | 178.96M | 120.31M | 28.55M | 296.04M | |||
| CHANGE IN CASH | 243.03M | 51.98M | 49.01M | -34.62M | 258.86M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -140.32M | -124.51M | -70.06M | -62.15M | -36.89M | |||
| Capital Expenditure | -2.19M | -2.46M | -1.24M | -1.02M | -290.00K | |||
| FREE CASH FLOW | -142.50M | -126.97M | -71.30M | -63.17M | -37.18M | |||
All data in USD